Página 2 - Melhores Quimioterapia para câncer do pulmão médicos - TOP-41 médicos

A Professora Felip lidera ensaios clínicos de câncer torácico no Hospital Quirón Barcelona, especializando-se na otimização da quimioterapia e na integração da imunoterapia para o câncer de pulmão.

• Membro atual do Grupo Espanhol de Câncer de Pulmão (Spanish Lung Cancer Group) e da ESMO
• Ganhadora do Prêmio ESMO Women for Oncology
• Copresidente do 20º Congresso WCLC em Barcelona
• Professora na Universitat de Vic, onde orienta fellows em oncologia

O Prof. Associado Atakan Topcu é especialista em câncer de pulmão e publicou mais de 50 artigos científicos sobre oncologia e cuidados geriátricos.

• Especialista em terapias-alvo e imunoterapia para tumores sólidos
• Membro da Sociedade Europeia de Oncologia Médica (ESMO)
• Realizou uma subespecialização (Fellowship) em Oncologia Médica na Universidade Bezmialem Vakıf
• Foca-se na desnutrição relacionada ao câncer e na oncologia geriátrica

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Especializado em oncologia médica com mais de 20 anos de experiência – O Dr. Ozden foca no tratamento personalizado do câncer de pulmão.

• Formado na Faculdade de Medicina Cerrahpaşa da Universidade de Istambul
• Subespecialidade em oncologia médica pela Universidade de Kocaeli
• Atuou como especialista em medicina interna por 12 anos
• Atualmente, exerce no Hospital VM Medical Park Pendik

Professor Associado de Oncologia Médica no Hospital Liv Topkapı da Universidade İstinye, com vasta experiência clínica e de pesquisa no tratamento do câncer de pulmão.

• Membro da Sociedade Americana de Oncologia Clínica (ASCO) desde 2018
• Publicou múltiplos estudos sobre os desfechos e a eficácia do tratamento do câncer de pulmão
• Especializa-se em protocolos de quimioterapia personalizados para pacientes com câncer de pulmão

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Dr. Kurt Rasche is a German pulmonologist with more than 40 years of clinical experience. He is Chief of Pulmonology at Helios University Hospital Wuppertal. He leads the departments of pulmonology, sleep medicine, and ventilation therapy. He also heads the certified Lung Cancer Center.

He is certified in internal medicine, pulmonology, allergology, sleep medicine, and intensive care. His clinical work focuses on diagnosing and treating chronic lung diseases, lung cancer, and sleep-related breathing disorders. He works closely with specialists from other fields to provide coordinated care.

O Dr. Raj Nagarkar realizou mais de 50.000 cirurgias oncológicas, especializando-se em Oncologia Cirúrgica de Mama e Tórax no HCG Manavata Cancer Centre.

• 19 anos de experiência em oncologia cirúrgica
• Formado no Tata Memorial Hospital e no Royal College of Surgeons
• Envolvido em mais de 200 ensaios clínicos
• Professor de Superespecialidade DNB em Oncologia Cirúrgica
• Foco na melhoria da qualidade de vida dos pacientes

A Dra. Shruti Kate é especialista no tratamento do cancro do pulmão e apresentou a sua investigação na Conferência Mundial sobre o Cancro do Pulmão em Toronto – a única beneficiária da bolsa de viagem da Índia.

• Formada no Tata Memorial Hospital – um centro oncológico de referência
• Especialista em imunoterapia e terapia metronómica para cancros avançados
• Membro da ASCO, ESMO e IASCLC – principais sociedades oncológicas
• Trata todos os tumores sólidos, incluindo cancros do pulmão e da mama

Realizou mais de 30.000 exames de PET e atendeu 1.000 pacientes com câncer de tireoide – O Dr. Borde traz ampla experiência em medicina nuclear para o tratamento do câncer de pulmão.

• 12 anos de experiência em medicina nuclear
• Especialista em exames de PET-CT e terapias com iodo radioativo
• Artigos publicados em diversas revistas médicas
• Atua no HCG Manavata Cancer Centre

O Dr. Shaunak apresentou pesquisas sobre cancro gástrico no prestigiado Gastrointestinal Cancer Symposium da ASCO. Especializa-se em terapias alvo e na base molecular do cancro.

• Concluiu o DNB em Oncologia Médica no Indraprastha Apollo Hospital
• Residência Sénior em Medicina Interna no Shyam Shah Medical College
• Registrar em Oncologia Médica no Jawaharlal Nehru Cancer Hospital
• Ministrou palestras na International Winter School of Oncology

O Dr. Lalit realizou mais de 10.000 cirurgias de grande porte, com foco em cirurgias de câncer minimamente invasivas para excelentes resultados.

• Fellowship em Oncologia Cirúrgica no Tata Medical Centre, Kolkata
• Especializa-se em cirurgias de câncer gastrointestinal
• Coinvestigador principal em múltiplos estudos de pesquisa originais
• Professor Assistente no Instituto Estadual do Câncer e Hospital Oncológico Governamental
• Reconhecido pela abordagem ética e amigável ao paciente

O Dr. Shaikh é especializado em preservação de órgãos e reabilitação funcional para pacientes com câncer oral, garantindo qualidade de vida.

• 3 anos de experiência em Oncologia Cirúrgica
• Experiência em grandes cirurgias maxilofaciais e de cabeça e pescoço
• Treinamento de subespecialidade (Fellowship) em Oncologia Cirúrgica de Cabeça e Pescoço
• Focado em higiene oral preventiva e diagnóstico precoce
• Pesquisador com múltiplas publicações na área

O Dr. Sridhar P.S. é um oncologista de radiação com formação especializada em radioterapia para o tratamento do cancro do pulmão.

• Mais de 20 anos de experiência em oncologia de radiação
• Formado em radioterapia na Banaras Hindu University
• Diplomado pelo National Board em radioterapia
• Membro de várias sociedades de oncologia de prestígio